Response to SGX Queries::

Issuer & Securities

Issuer/ Manager
PHARMESIS INTERNATIONAL LTD.
Securities
PHARMESIS INTERNATIONAL LTD. - SG1BH6000003 - BFK
Stapled Security
No

Announcement Details

Announcement Title
Response to SGX Queries
Date &Time of Broadcast
14-Mar-2024 18:10:43
Status
New
Supplementary Title
On Financial Statements
Announcement Reference
SG240314OTHRCA7L
Submitted By (Co./ Ind. Name)
Wu Xuedan
Designation
Executive Director and Chief Executive Officer
Description (Please provide a detailed description of the change in the box below)
Please refer to the attachment.

Attachments

Pharmesis - Response to SGX Queries - 14.03.2024.pdf
Total size =163K